BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28019110)

  • 1. Severe Kaposi Sarcoma in an Urban Public Hospital.
    Kasturia SE; Gunthel C; Zeng C; Nguyen ML
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):583-589. PubMed ID: 28019110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
    Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
    AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma: a reevaluation.
    Orfanos CE; Husak R; Wölfer U; Garbe C
    Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroids are a risk factor for Kaposi's sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection.
    Fernández-Sánchez M; Iglesias MC; Ablanedo-Terrazas Y; Ormsby CE; Alvarado-de la Barrera C; Reyes-Terán G
    AIDS; 2016 Mar; 30(6):909-14. PubMed ID: 26636923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.
    Martín-Carbonero L; Palacios R; Valencia E; Saballs P; Sirera G; Santos I; Baldobí F; Alegre M; Goyenechea A; Pedreira J; González del Castillo J; Martínez-Lacasa J; Ocampo A; Alsina M; Santos J; Podzamczer D; González-Lahoz J;
    Clin Infect Dis; 2008 Aug; 47(3):410-7. PubMed ID: 18582203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of Kaposi sarcoma in the past 30 years in a tertiary hospital of the European Mediterranean basin.
    Marcoval J; Bonfill-Ortí M; Martínez-Molina L; Valentí-Medina F; Penín RM; Servitje O
    Clin Exp Dermatol; 2019 Jan; 44(1):32-39. PubMed ID: 29934954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and survival for HIV-associated multicentric Castleman disease in Malawi.
    Gopal S; Liomba NG; Montgomery ND; Moses A; Kaimila B; Nyasosela R; Chikasema M; Dhungel BM; Kampani C; Sanders MK; Krysiak R; Dittmer DP; Fedoriw Y
    J Int AIDS Soc; 2015; 18(1):20122. PubMed ID: 26242311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children.
    Gantt S; Kakuru A; Wald A; Walusansa V; Corey L; Casper C; Orem J
    Pediatr Blood Cancer; 2010 May; 54(5):670-4. PubMed ID: 20205254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
    Mocroft A; Kirk O; Clumeck N; Gargalianos-Kakolyris P; Trocha H; Chentsova N; Antunes F; Stellbrink HJ; Phillips AN; Lundgren JD
    Cancer; 2004 Jun; 100(12):2644-54. PubMed ID: 15197808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe.
    Nelson BC; Borok MZ; Mhlanga TO; Makadzange AT; Campbell TB
    Int J Infect Dis; 2013 Oct; 17(10):e902-6. PubMed ID: 23809198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm³ at presentation.
    Daly ML; Fogo A; McDonald C; Morris-Jones R
    Clin Exp Dermatol; 2014 Jan; 39(1):7-12. PubMed ID: 23691969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.
    Grabar S; Abraham B; Mahamat A; Del Giudice P; Rosenthal E; Costagliola D
    J Clin Oncol; 2006 Jul; 24(21):3408-14. PubMed ID: 16849755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Profile of Kaposi sarcoma patients in the competence network HIV/AIDS].
    Klingenberg RE; Esser S; Brockmeyer NH; Michalik C; Skaletz-Rorowski A; Potthoff A;
    Hautarzt; 2018 Feb; 69(2):143-148. PubMed ID: 29101417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal pulmonary Kaposi sarcoma in an HIV seronegative AIDS patient.
    Zhang H; Wang HL; Zhong DR; Liu Y; Li NN; Zhang W; Xiao Y; Li TS
    Clin Respir J; 2017 Nov; 11(6):1040-1044. PubMed ID: 26861193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
    El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
    AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admitted AIDS-associated Kaposi sarcoma patients: Indications for admission and predictors of mortality.
    Vally F; Selvaraj WMP; Ngalamika O
    Medicine (Baltimore); 2020 Sep; 99(39):e22415. PubMed ID: 32991474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria.
    Agaba PA; Sule HM; Ojoh RO; Hassan Z; Apena L; Mu'azu MA; Badung B; Agbaji OO; Idoko JA; Kanki P
    Int J STD AIDS; 2009 Jun; 20(6):410-3. PubMed ID: 19451327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One hundred and five Kaposi sarcoma patients: a clinical study in Xinjiang, Northwest of China.
    Wu XJ; Pu XM; Kang XJ; Halifu Y; An CX; Zhang DZ; Yakeya B; Mijit J
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1545-52. PubMed ID: 25350316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predictive of disease progression and death in AIDS-related Kaposi's sarcoma.
    Spano JP; Salhi Y; Costagliola D; Rozenbaum W; Girard PM
    HIV Med; 2000 Oct; 1(4):232-7. PubMed ID: 11737354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.
    Volkow P; Cesarman-Maus G; Garciadiego-Fossas P; Rojas-Marin E; Cornejo-Juárez P
    AIDS Res Ther; 2017 May; 14(1):30. PubMed ID: 28558783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.